SCHEMBL1492870

SCHEMBL1492870

Cc1cccc(NC(=O)Nc2ccc(-c3ccnc(C)c3)cc2)c1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PSEN1 P49768 9/20 0.67
PSEN2 P49810 9/20 0.67
APH1B Q8WW43 9/20 0.67
NCSTN Q92542 9/20 0.67
APH1A Q96BI3 9/20 0.67
PSENEN Q9NZ42 9/20 0.67
PKM P14618 1/20 0.62
KMT2A Q03164 1/20 0.62
SMN1; SMN2 Q16637 1/20 0.62
FLT1 P17948 3/20 0.62
FLT3 P36888 3/20 0.62
CSF1R P07333 2/20 0.62
IMPDH2 P12268 2/20 0.59
CYP3A4 P08684 1/20 0.58
KIT P10721 2/20 0.58
KDR P35968 2/20 0.58
PLK4 O00444 1/20 0.58
AURKA O14965 1/20 0.58
ROCK2 O75116 1/20 0.58
RPS6KA5 O75582 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1493028 0.89 PSEN1 (0.68) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL1492860 0.88 CNR1 (0.68) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL1492777 0.87 NPC1 (0.63) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL1492821 0.87 PSEN1 (0.63) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL1493023 0.86 CNR1 (0.65) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL1492826 0.85 PSEN1 (0.61) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL1492843 0.85 NPC1 (0.64) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL1492908 0.85 MAPT (0.61) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL1492969 0.85 PSEN1 (0.67) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL1781477 0.85 PSEN1 (0.61) PSEN1PSEN2APH1BNCSTNAPH1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110118234-A1 Urea Compounds as Gamma Secretase Modulators AMGEN INC. 2011-05-19 US claimed
EP-2300427-A1 UREA COMPOUNDS AS GAMMA SECRETASE MODULATORS AMGEN INC. (US) 2011-03-30 EP claimed
WO-2009137404-A1 UREA COMPOUNDS AS GAMMA SECRETASE MODULATORS AMGEN INC. (US) 2009-11-12 WO claimed
US-20110118234-A1 Urea Compounds as Gamma Secretase Modulators AMGEN INC. 2011-05-19 US disclosed
US-20110118234-A1 Urea Compounds as Gamma Secretase Modulators AMGEN INC. 2011-05-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110118234-A1 Urea Compounds as Gamma Secretase Modulators BACE1, BACE2, PSEN1 PSEN1 3/4885PSEN2 4/4885APH1B 6/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.